Bay Street News, February, 2024

CORAL GABLES, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused [...]

Key Q4 and Full Year 2023 Highlights Revenue and Adj. Revenue(1): Q4 $953M / FY $3,722M Pre-tax Income (Loss): Q4 […]

LOUISVILLE, Colo., Feb. 14, 2024 (GLOBE NEWSWIRE) — Solid Power, Inc. (Nasdaq: SLDP), a developer of solid-state battery technology, today […]

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — IN8bio, Inc. (NASDAQ: INAB), a leading clinical-stage biopharmaceutical company developing innovative gamma-delta […]

Clinical results show that Tonyma™ has broad-spectrum activity, addressing the three core fibromyalgia symptoms: pain, fatigue, and sleep disturbance Tonmya™ […]

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), […]

IRVINE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced […]

Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) […]

PLANO, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions […]

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness […]